Literature DB >> 26923296

Pancreatic adenocarcinoma.

Mariam F Eskander1, Lindsay A Bliss1, Jennifer F Tseng2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26923296     DOI: 10.1067/j.cpsurg.2016.01.001

Source DB:  PubMed          Journal:  Curr Probl Surg        ISSN: 0011-3840            Impact factor:   1.909


× No keyword cloud information.
  4 in total

1.  Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma.

Authors:  Gurshawn Singh; Ammar Nassri; David Kim; Hong Zhu; Zeeshan Ramzan
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-02-06

2.  Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies.

Authors:  R Vera; A Ferrández; C J Ferrer; C Flores; C Joaquín; S López; T Martín; E Martín; M Marzo; A Sarrión; E Vaquero; A Zapatero; J Aparicio
Journal:  Clin Transl Oncol       Date:  2017-01-19       Impact factor: 3.405

3.  MCOLN1 Promotes Proliferation and Predicts Poor Survival of Patients with Pancreatic Ductal Adenocarcinoma.

Authors:  Zhan-Dong Hu; Jun Yan; Kai-Yue Cao; Zhi-Qi Yin; Wei-Wei Xin; Ming-Fang Zhang
Journal:  Dis Markers       Date:  2019-08-05       Impact factor: 3.434

4.  Radiomics Facilitates Candidate Selection for Irradiation Stents Among Patients With Unresectable Pancreatic Cancer.

Authors:  Hai-Feng Zhou; Yu-Qi Han; Jian Lu; Jing-Wei Wei; Jin-He Guo; Hai-Dong Zhu; Ming Huang; Jian-Song Ji; Wei-Fu Lv; Li Chen; Guang-Yu Zhu; Zhi-Cheng Jin; Jie Tian; Gao-Jun Teng
Journal:  Front Oncol       Date:  2019-09-27       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.